Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic cancer community.
OCRA’s Advocates are beginning 2024 with great momentum. Here’s a look at our most impactful achievements in 2023:
Co-founded a coalition to address the current chemotherapy drug shortage and prevent future shortages.
Nearly 300 advocates from 44 states met with 380+ Congressional offices to push for important initiatives, including expanded Medicare coverage of life-saving tools like genetic testing, at OCRA’s Spring and Fall Advocacy Days.
Secured 19 new co-sponsors on targeted legislation for federal education and awareness programs as a result of our Fall Advocacy Day.
Spearheaded Dear Colleague letters in both the U.S. House and Senate calling for an increase to $50 million for the Congressionally Directed Medical Research Program’s Ovarian Cancer Research Program. The bipartisan letters were signed by almost 100 legislators.
Initiated a research project to identify health disparities within gynecologic cancer outcomes, with an initial focus on racial and geographic disparities in care.
As the largest organization advocating on behalf of patients, survivors and families of those facing ovarian and related gynecologic cancers, OCRA is committed to effecting legislative change that can prevent more diagnoses, improve outcomes, and ease the financial burden of treatment and care.
Written by Chad Ramsey, Vice President, Policy February brought meaningful progress in Washington. From major legislative wins to the start of a new appropriations cycle, advocates are already helping shape the policy landscape for ovarian and gynecologic cancer patients in 2026 and beyond. State-Level Momentum: Biomarker Progress Continues Momentum is building across the country to … Continued
Written by Chad Ramsey, OCRA’s Vice President, Policy OCRA’s Advocate Leader Program Reaches Record Size in 2026 January marked a major milestone for Ovarian Cancer Research Alliance’s (OCRA) advocacy community. OCRA trained 94 new advocates to join our Advocate Leaders program, bringing our total to 227 advocates across 44 states and Washington, DC. This is … Continued
This action alert is now closed. View an update on the FY2026 funding package. The Congressional Appropriations Committees have released a combined FY2026 Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
